InvestSMART

Burgundy Diamond Mines Limited (ASX: BDM) - Announcements

- Current share price for BDM : $0.017

ASX company news and announcements for Burgundy Diamond Mines Limited (BDM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Burgundy Diamond Mines Limited (BDM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Burgundy Diamond Mines Limited (BDM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Burgundy Diamond Mines Limited (BDM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Appendix 2A 24 Mar 2021 1:17PM $0.380 $0.017 fallen by 95.53%
$24 GIB: Sale of Option Over Ellendale Diamond Project 24 Mar 2021 9:45AM $0.390 $0.017 fallen by 95.64%
$24 Burgundy secures option to acquire Ellendale Diamond Project 24 Mar 2021 8:21AM $0.390 $0.017 fallen by 95.64%
$24 Appendix 2A - Release of escrowed securities 19 Mar 2021 2:58PM $0.390 $0.017 fallen by 95.64%
$24 Half Yearly Report and Accounts 12 Mar 2021 5:18PM $0.380 $0.017 fallen by 95.53%
$24 Burgundy presentation at virtual PDAC conference 8 Mar 2021 10:01AM $0.350 $0.017 fallen by 95.14%
$24 Securities to be released from escrow 3 Mar 2021 6:40PM $0.340 $0.017 fallen by 95%
$24 Botswana Drilling Update 1 Mar 2021 11:15AM $0.390 $0.017 fallen by 95.64%
$24 Response to ASX Price Query 24 Feb 2021 6:12PM $0.270 $0.017 fallen by 93.70%
$24 Burgundy expands exploration portfolio in Botswana 17 Feb 2021 8:06AM $0.215 $0.017 fallen by 92.09%
$24 Quarterly Activities Report and Appendix 5B 29 Jan 2021 4:36PM $0.190 $0.017 fallen by 91.05%
$24 Letter to Shareholders 13 Jan 2021 1:35PM $0.160 $0.017 fallen by 89.38%
$24 Appendix 2A and Cleansing Statement 10 Dec 2020 2:39PM $0.190 $0.017 fallen by 91.05%
$24 Response to ASX Price Query 9 Dec 2020 4:22PM $0.235 $0.017 fallen by 92.77%
$24 Change of Director's Interest Notice 23 Nov 2020 2:23PM $0.100 $0.017 fallen by 83%
$24 Appendix 3G 23 Nov 2020 1:41PM $0.100 $0.017 fallen by 83%
$24 Suspension from Official Quotation - 8 November, 2013 7 Nov 2013 4:52PM $0.039 $0.017 fallen by 56.41%
$24 Appendix 4C - quarterly 30 Oct 2013 1:59PM $0.040 $0.017 fallen by 57.50%
$24 Delisting Update 28 Oct 2013 9:43AM $0.037 $0.017 fallen by 54.05%
$24 BDM-I Study Results presented at Interscience Conference 16 Sep 2013 9:34AM $0.045 $0.017 fallen by 62.22%
$24 Appendix 4E and Statutory Accounts 27 Aug 2013 9:53AM $0.062 $0.017 fallen by 72.58%
$24 BioDiem US patent for skin and wound infections 23 Aug 2013 10:27AM $0.060 $0.017 fallen by 71.67%
$24 Appendix 4C - quarterly 31 Jul 2013 9:39AM $0.080 $0.017 fallen by 78.75%
$24 Proof of Principle shown in Liver Disease Vaccine Program 22 Jul 2013 9:54AM $0.050 $0.017 fallen by 66%
$24 Griffith Uni study enhances BioDiem's antimicrobial program 11 Jul 2013 10:32AM $0.036 $0.017 fallen by 52.78%

301 - 325 of 458 results

Page 13 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.